Literature DB >> 25526738

A computational model of unresolved allergic inflammation in chronic asthma.

Joshua J Pothen1, Matthew E Poynter1, Jason H T Bates2.   

Abstract

We have previously developed an agent-based computational model to demonstrate the feasibility of a novel hypothesis we term the inflammatory twitch. This hypothesis potentially explains the dynamics of the normal response to allergic inflammation in the lung (Pothen JJ, Poynter ME, Bates JH. J Immunol 190: 3510-3516, 2013) on the basis that antigenic stimulation sets in motion both the onset of inflammation and its subsequent resolution. The result is a self-limited inflammatory event that is similar in a formal sense to a skeletal muscle twitch. We hypothesize here that the chronic airway inflammation characteristic of asthma may represent the failure of the inflammatory twitch to resolve back to baseline. Our model provides a platform with which to perform virtual experiments aimed at investigating possible mechanisms leading to accentuation and/or prolongation of the inflammatory twitch. We used our model to determine how the inflammatory twitch is modified by knocking out certain cell types, interfering with cell activity, and altering cell lifetimes. Increasing the duration of activation of proinflammatory cells (considered to be chiefly neutrophils and eosinophils) markedly accentuated and prolonged the inflammatory twitch. This aberrant twitch behavior was largely abrogated by knocking out T-helper cells (simulating the effect of corticosteroids). The aberrant inflammatory twitch was also normalized by reducing the lifetime of the proinflammatory cells, suggesting that increasing apoptosis of these cells may be a therapeutic target in asthma.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  agent-based computational model; chronic inflammation

Mesh:

Year:  2014        PMID: 25526738      PMCID: PMC4329472          DOI: 10.1152/ajplung.00268.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  22 in total

Review 1.  New insights into the role of the mast cell in asthma.

Authors:  C E Brightling; P Bradding; I D Pavord; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2003-05       Impact factor: 5.018

Review 2.  Mechanisms of alveolar protein clearance in the intact lung.

Authors:  Randolph H Hastings; Hans G Folkesson; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-04       Impact factor: 5.464

3.  Comparative diffusion of drugs through bronchial tissue.

Authors:  Johann M van Zyl; Brigitta Derendinger; Heiner I Seifart; Pieter Van der Bijl
Journal:  Int J Pharm       Date:  2008-01-20       Impact factor: 5.875

4.  Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand.

Authors:  K L Serrao; J D Fortenberry; M L Owens; F L Harris; L A Brown
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-02       Impact factor: 5.464

5.  Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.

Authors:  Hélène Salmon; Katarzyna Franciszkiewicz; Diane Damotte; Marie-Caroline Dieu-Nosjean; Pierre Validire; Alain Trautmann; Fathia Mami-Chouaib; Emmanuel Donnadieu
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 6.  Dendritic cells in asthma: a function beyond sensitization.

Authors:  L S van Rijt; B N Lambrecht
Journal:  Clin Exp Allergy       Date:  2005-09       Impact factor: 5.018

7.  An agent-based model of inflammation and fibrosis following particulate exposure in the lung.

Authors:  Bryan N Brown; Ian M Price; Franklin R Toapanta; Dilhari R DeAlmeida; Clayton A Wiley; Ted M Ross; Tim D Oury; Yoram Vodovotz
Journal:  Math Biosci       Date:  2011-03-06       Impact factor: 2.144

8.  Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling.

Authors:  H Tanaka; T Masuda; S Tokuoka; Y Takahashi; M Komai; K Nagao; H Nagai
Journal:  Inflamm Res       Date:  2002-06       Impact factor: 4.575

Review 9.  Current and emerging therapies for the management of chronic inflammation in asthma.

Authors:  Carrie J DeKorte
Journal:  Am J Health Syst Pharm       Date:  2003-10-01       Impact factor: 2.637

10.  Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.

Authors:  M K Church; J Hiroi
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

View more
  6 in total

1.  Dissecting the inflammatory twitch in allergically inflamed mice.

Authors:  Joshua J Pothen; Matthew E Poynter; Lennart K A Lundblad; Jason H T Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-04       Impact factor: 5.464

Review 2.  Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action.

Authors:  Seegehalli M Anil; Hadar Peeri; Hinanit Koltai
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

Review 3.  Systems physiology of the airways in health and obstructive pulmonary disease.

Authors:  Jason H T Bates
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-06-24

Review 4.  Pathophysiology to Phenotype in the Asthma of Obesity.

Authors:  Jason H T Bates; Matthew E Poynter; Christa M Frodella; Ubong Peters; Anne E Dixon; Benjamin T Suratt
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 5.  Multiplicity of Mathematical Modeling Strategies to Search for Molecular and Cellular Insights into Bacteria Lung Infection.

Authors:  Martina Cantone; Guido Santos; Pia Wentker; Xin Lai; Julio Vera
Journal:  Front Physiol       Date:  2017-08-30       Impact factor: 4.566

6.  Mathematical modeling of ventilator-induced lung inflammation.

Authors:  Sarah Minucci; Rebecca L Heise; Michael S Valentine; Franck J Kamga Gninzeko; Angela M Reynolds
Journal:  J Theor Biol       Date:  2021-04-27       Impact factor: 2.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.